3 active not recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 3 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow control: new trials by email Literature Review of control trials Research Report on control
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opt-IVF for Personalized Medicine for Normal Responders Opt-IVF, control - Ivf | Phase 1 / Phase 2 | Active not recruiting | Urmila DIwekar | 100 | 2026-10-15 | 2026-11-03 |
| Morning-Evening Specific Longevity Food Supplement Morning- and evening-specific compound food supplement, Control - Aging | Phase 1 | Active not recruiting | University of Primorska | 60 | 2026-03-07 | 2026-03-11 |
| A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA) SOC + TSC-101, Control, SOC + TSC-100 - AML, MDS | Phase 1 | Active not recruiting | TScan Therapeutics, Inc. | 310 | 2022-11-01 | 2026-10-05 |
Infertility (1) · Long Qt Syndrome 3 (1) · Sleep Initiation and Maintenance Disorders (1)
TScan Therapeutics, Inc. (1) · University of Primorska (1) · Urmila DIwekar (1)
United States (2) · Slovenia (1)
Dr. Paul Magarelli, M.D., Ph.D. (1) · Shrikanta Chattopadhyay, MD (1)